» Articles » PMID: 30202987

Factors Associated with Prescription Opioid Analgesic Use in the US Population, 2011-2014

Overview
Journal Pain Med
Date 2018 Sep 12
PMID 30202987
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study examined factors associated with prescription opioid analgesic use in the US population using data from a nationally representative sample. It focused on factors previously shown to be associated with opioid use disorder or overdose. Variations in the use of different strength opioid analgesics by demographic subgroup were also examined.

Methods: Data came from respondents aged 16 years and older who participated in the National Health and Nutrition Examination Survey (2011-2014). Respondents were classified as opioid users if they reported using one or more prescription opioid analgesics in the past 30 days.

Results: Opioid users reported poorer self-perceived health than those not currently using opioids. Compared with those not using opioids, opioid users were more likely to rate their health as being "fair" or "poor" (40.4% [95% confidence interval {CI} = 34.9%-46.2%] compared with 15.6% [95% CI = 14.3%-17.1%]), experienced more days of pain during the past 30 days (mean = 14.3 [95% CI = 12.9-15.8] days compared with 2.3 [95% CI = 2.0-2.7] days), and had depression (22.5% [95% CI = 17.3%-28.7%] compared with 7.1% [95% CI = 6.2%-8.0%]). Among those who reported using opioids during the past 30 days, 18.8% (95% CI = 14.4%-24.1%) reported using benzodiazepine medication during the same period and 5.2% (95% CI = 3.5%-7.7%) reported using an illicit drug during the past six months. When opioid strength was examined, a smaller percentage of adults aged 60 years and older used stronger-than-morphine opioids compared with adults aged 20-39 and 40-59 years.

Conclusions: Higher percentages of current opioid users than nonusers reported having many of the factors associated with opioid use disorder and overdose.

Citing Articles

Observational evidence linking psychotropic medicines to the dispensing of opioid agents in later life.

Almeida O, Page A, Sanfilippo F, Preen D, Etherton-Beer C Psychogeriatrics. 2024; 24(3):665-674.

PMID: 38561326 PMC: 11578014. DOI: 10.1111/psyg.13123.


Sociocultural factors associated with persistent prescription opioid use (PPOU) among Puerto Rican adults in Massachusetts.

Essien-Aleksi I, Zhang Y, Koren A, Palacios N, Falcon L, Tucker K PLoS One. 2023; 18(8):e0290104.

PMID: 37607191 PMC: 10443880. DOI: 10.1371/journal.pone.0290104.


Chronic Pain, Opioid Use Disorder, and Clinical Management Among Older Adults.

Potru S, Tang Y Focus (Am Psychiatr Publ). 2021; 19(3):294-302.

PMID: 34690595 PMC: 8475938. DOI: 10.1176/appi.focus.20210002.


Patterns of opioid use (codeine, morphine or meperidine) in the Canadian population over time: analysis of the Longitudinal National Population Health Survey 1994-2011.

Canizares M, Power J, Rampersaud Y, Badley E BMJ Open. 2019; 9(7):e029613.

PMID: 31345978 PMC: 6661673. DOI: 10.1136/bmjopen-2019-029613.

References
1.
Frenk S, Porter K, Paulozzi L . Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief. 2015; (189):1-8. View

2.
Atluri S, Sudarshan G, Manchikanti L . Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014; 17(2):E119-28. View

3.
Mojtabai R . National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2017; 27(5):526-534. DOI: 10.1002/pds.4278. View

4.
Gwira Baumblatt J, Wiedeman C, Dunn J, Schaffner W, Paulozzi L, Jones T . High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014; 174(5):796-801. DOI: 10.1001/jamainternmed.2013.12711. View

5.
. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep. 2011; 60(43):1487-92. View